Phosphodiesterase Type 5 Inhibitors and Visual Side Effects: A Narrative Review
Phosphodiesterase type 5 inhibitors such as sildenafil citrate and tadalafil are well known for the treatment of erectile dysfunction. However, their use in the presence of pulmonary hypertension can cause ophthalmologic side effects, including non-arteritic optic ischemic neuropathy, chorioretinopa...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Knowledge E
2021-05-01
|
Series: | Journal of Ophthalmic & Vision Research |
Subjects: | |
Online Access: | https://doi.org/10.18502/jovr.v16i2.9088 |